Assessment of the application of complimentary substances and methods in skin cancer patients

• Conditions: scin cancer; C43-C44; Melanoma and other malignant neoplasms of skin

• Registration Number: DRKS00003718
• Lead Sponsor: ADO Tübingen / (PRIO) der Deutschen Krebsgesellschaft (DKG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-05-15
• Study Completion: 2015-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1189

Inclusion Criteria

All patients with skin cancer who are advised and treated at a skin cancer center
- A signed consent form
- Age> 18 years

Exclusion Criteria

- Linguistic or other restrictions that prevent the independent completion of the questionnaire
- Lack of informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
For each patient using a standardized questionnaire, the use of complementary and alternative therapies (CAM) is applicable. Patients when entering the skin cancer center will be asked regarding their treatment and aftercare at defined time points (1. admission to the skin cancer center, 2.: during treatment (number of surveys available, survey each in therapy change), 3. Aftercare () several surveys possible elevation at each follow-up visit. Data will be collected on larger collectives of different skin tumor entities on user behavior of patients from skin cancer centers in different provinces levied.

Secondary Outcome Measures

Name	Time	Method
The data on user behavior will be correlated to data for the individual patient's situation, history and treatment.<br>1. Motivation for the use of KAM<br>2. Influence of certain situations on the decision of therapy for patients KAM<br>3. <br>Patient´s assessment regarding treatment efficacy<br>4. <br>Extent of the potential interactions with anti-tumor therapy<br>5.<br>Influence of the use of CAM in the course of therapy<br>6.<br>Supportive effect of KAM<br>7.<br>Negative effects of KAM on progression-free survival and overall survival<br>8.<br>Evaluation of the questionnaire as a screening tool for the detection of user behavior regarding complementary and alternative therapies for skin cancer patients